Essay Examines Access Issues Surrounding Medicines For NCDs In Developing Countries

In an essay published in PLOS Medicine, Thomas Bollyky, a senior fellow for global health, economics and development at the Council on Foreign Relations (CFR), examines “new controversy [emerging] over patented medicines [for non-communicable diseases (NCDs)] and their affordability in developing countries.” He notes, “India, China, and other middle-income countries have taken measures to circumvent patents on medicines for diabetes, cancer, and cardiovascular and chronic respiratory illnesses — the [NCDs] increasing most rapidly in low- and middle-income countries,” and he writes, “Addressing this latest treatment-access crisis will require another transformation in global health [similar to that which took place surrounding HIV/AIDS], this time focusing on NCDs, low-cost interventions, and patient-centered strategies” (7/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.